Expanding Access to Our Medicines
Have Questions About Participating in a COVID-19 Vaccine Clinical Trial? A Doctor Overseeing a Study Helps Answer ThemDid you like reading this story? Click the heart to show your love.
Johnson & Johnson Joins Other Companies in Signing a Landmark Communiqué on Expanded Global Access for COVID-19Did you enjoy reading this story? Click the heart.
Did you like taking this quiz? Click the heart to show your love.
Every day, 1,000 young women and girls get HIV, 4,000 lives are lost to TB, and millions who could be helped suffer from serious mental illnesses. Johnson & Johnson's efforts in tackling these health threats, alongside many others, is why the company has continued to rank among the top three working to expand global access to medicines in low- and middle-income countries according to the Access to Medicine Index (ATMI).